首页 产品目录 分子砌块 按反应类型 氨基甲酸酯合成 (2S,3R,4S,5S,6R)-2-[[(2R,3R,4S,5S,6R)-4,5-二羟基-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-羟基-4,4,8,10,14-五甲基-17-[(S)-6-甲基-2-[[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-[[(2S,3R,4S,5R)-3,4,5-三羟基四氢-2H-吡喃-2-基]氧基甲基]四氢-2H-吡喃-2-基]氧基甲基]四氢-2H-吡喃-2-基]氧基]庚-5-烯-2-基]十六氢-1H-环戊并[a]菲-3-基]氧基]-6-(羟甲基)四氢-2H-吡喃-3-基]氧基]-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇

(2S,3R,4S,5S,6R)-2-[[(2R,3R,4S,5S,6R)-4,5-二羟基-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-羟基-4,4,8,10,14-五甲基-17-[(S)-6-甲基-2-[[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-[[(2S,3R,4S,5R)-3,4,5-三羟基四氢-2H-吡喃-2-基]氧基甲基]四氢-2H-吡喃-2-基]氧基甲基]四氢-2H-吡喃-2-基]氧基]庚-5-烯-2-基]十六氢-1H-环戊并[a]菲-3-基]氧基]-6-(羟甲基)四氢-2H-吡喃-3-基]氧基]-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇

(2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5S,6R)-4,5-Dihydroxy-2-(((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((S)-6-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)hept-5-en-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 98% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

87741-77-3

中文名称

(2S,3R,4S,5S,6R)-2-[[(2R,3R,4S,5S,6R)-4,5-二羟基-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-羟基-4,4,8,10,14-五甲基-17-[(S)-6-甲基-2-[[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-[[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-[[(2S,3R,4S,5R)-3,4,5-三羟基四氢-2H-吡喃-2-基]氧基甲基]四氢-2H-吡喃-2-基]氧基甲基]四氢-2H-吡喃-2-基]氧基]庚-5-烯-2-基]十六氢-1H-环戊并[a]菲-3-基]氧基]-6-(羟甲基)四氢-2H-吡喃-3-基]氧基]-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇

英文名称

(2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5S,6R)-4,5-Dihydroxy-2-(((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((S)-6-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)hept-5-en-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

别名

β-D-Glucopyranoside, (3β,12β)-12-hydroxy-20-[(O-β-D-xylopyranosyl-(1→6)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]dammar-24-en-3-yl 2-O-β-D-glucopyranosyl-;Notoginsenoside R4;β-D-Glucopyranoside, (3β,12β)-12-hydroxy-20-[(O-β-D-xylopyranosyl-(1→6)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]dammar-24-en-3-yl 2-O-β-D-glucopyranosyl-

标准英文名

Notoginsenoside R4

分子式

C59H100O27

分子量

1241.42

精确分子量

1240.65

SMILES

CC(C)=CCC[C@@]([C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@H]3[C@@]2(C)CC[C@@H]4[C@]3(C)CC[C@H](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O)[C@H](O)[C@@H](CO)O5)C4(C)C)(O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]8[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]9[C@H](O)[C@@H](O)[C@H](O)CO9)O8)O7)C

标准SMILES

CC1(C)[C@@H]2CC[C@]3(C)[C@H](C[C@@H](O)[C@@H]4[C@H](CC[C@@]34C)[C@](C)(CCC=C(C)C)O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO[C@@H]5OC[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)[C@@]2(C)CC[C@@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

性状

No data available

用途

For laboratory research purposes. Not for drug or household use.

信号词

Warning

InChIKey

IWDYQBDCEDNTDP-BHPIZNGBSA-N

危险类别(旧)

H302,H315,H319

存储要求

No data available,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage.

安全信息

危险品分类

Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A)

化学稳定性

Stable under recommended storage conditions.

符号

SureRoute逆合成路线

1.  87741-77-3 逆合成路线 1

—
—
ACGSHV034
87741-77-3
来源: SureRoute

2.  87741-77-3 逆合成路线 2

—
—
ACGSHV034
87741-77-3
来源: SureRoute

3.  87741-77-3 逆合成路线 3

—
—
ACGSHV034
87741-77-3
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手